The U.S. corporate/M&A team represents a wide range of leading U.S. and international corporations, financial institutions and private equity funds. The team has extensive experience with both public and private domestic and cross-border transactions.
Representative experience includes advising:
Novartis in its transformational restructuring involving three strategic deals with GlaxoSmithKline (GSK), including the acquisition of GSK’s oncology division, the sale of Novartis’ vaccines business and the creation of a joint venture involving the combination of Novartis’ OTC business with GSK’s consumer healthcare business
AMEC in connection with its acquisition of Foster Wheeler
Visa Europe Limited on the sale of 100% of its share capital to Visa Inc.
Petrochemical Industries Company K.S.C. in the US$3.2bn sale of MEGlobal, together with its joint venture partner Dow Chemical, to EQUATE Petrochemical Company K.S.C.C.
Qatar Holding L.L.C., an affiliate of the Qatar Investment Authority, along with funds under management by BlackRock, Macquarie, Teacher Retirement System of Texas and Certares on the US$1.8bn acquisition of a 50% stake in American Express' Global Business Travel unit (2015 Private Equity Deal of the Year, IFLR Americas Awards)
ASSA ABLOY on its acquisitions of Amarr Company, Ameristar Fence Products and 4Front Engineered Solutions
ThyssenKrupp on the sale of its U.S. steel plant to ArcelorMittal and Nippon Steel & Sumitomo Metal Corp.
Deutsche Börse on its terminated merger with NYSE-Euronext to create the world’s largest stock exchange by revenue and profits
E-Land World Ltd. on its US$170m acquisition of K-Swiss, Inc.
IFM Investors on its US$1.3bn investment for Freeport LNG's proposed natural gas liquefaction and LNG loading facility on Quintana Island near Freeport, Texas
Vodafone on its £9.1bn offer for Kabel Deutschland
a major automobile rental company on the global investment in and strategic cooperation with a major Chinese auto rental company
Queijo Holding Corp., a vehicle of the controlling stockholders – Acquisition of the all of the shares not owned by the controlling shareholders in Brazil Fast Food Corp., valuing the latter at US$148.3m
Actavis on its €4.25bn sale to Watson Pharmaceuticals
Sanofi-aventis on its acquisition of Merck & Co.’s half of joint venture Merial, an animal-health company
Amil Participações on its US$4.9bn investment agreement with UnitedHealthcare (2013 Global M&A Deal of the Year (Brazil), The American Lawyer Global Legal Awards)
a consortium of sovereign wealth and private equity investors on a US$1.8bn acquisition of a minority stake in Banco BTG Pactual (2011 Best Private Equity Deal of the Year, Latin Finance Magazine)
Gold Fields, National Grid, RBS, Rio Tinto, Sibanye Gold and Vodafone on SEC-related matters, including reporting and corporate governance